ESMO Open published a clinical update in Oncology on 10 Mar 2026. The item focuses on TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer. Review the original article for the full source wording and details.
ESMO Open published a clinical update in Oncology on 10 Mar 2026.
The item focuses on TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer.
Review the original article for the full source wording and details.